FFC#13/2017

Induction of viable but non-culturable forms, possibly responsible for treatment failure, in vitro biofilms of Pseudomonas aeruginosa. Role of antibiotics and antibiotic concentrations

AREA 3 Bronchopulmonary infection

FFC#13/2017

Induction of viable but non-culturable forms, possibly responsible for treatment failure, in vitro biofilms of Pseudomonas aeruginosa. Role of antibiotics and antibiotic concentrations
€ 0 still needed
0%
€ 27.000 goal

pRINCIPAL INVESTIGATOR

Francesca Biavasco (Dipartimento di Scienze della Vita e dell’Ambiente, Università Politecnica delle Marche)

Researchers

6

Category

AREA 3 Bronchopulmonary infection

Duration

2 years

Goal

€ 27.000

Funds raised

€ 27.000

Objectives

Pseudomonas aeruginosa (P.a.) pulmonary infection tends to become chronic in CF. Researchers focus on the hypothesis that viable but non-culturable (VBNC) bacteria are implicated in chronic P.a. infection. VBNC are dormant bacterial forms, which are favoured by pulmonary CF environment. They are difficult to detect since don’t grow in common culture media and therefore need specific molecular techniques. This project aims to investigate the role of antibiotic treatment in the emergence and persistence of VBNC P. aeruginosa forms through the study of in vitro biofilms of P.a.; further to develop non-cultural assays capable of detecting and counting VBNC P.a. cells in patient samples. A more reliable microbiological diagnosis of P.a. infection through the representation of its actual pulmonary colonization, also encompassing dormant forms, is expected; and effective antimicrobial treatments capable of contrasting, or at least containing, the development of biofilm and persistent bacterial forms.

WHO ADOPTED THE PROJECT

Lifc Toscana Onlus

€ 27.000

“Un fiore per Valeria” Assemini – Cagliari

€ 8.000

Gruppo di Sostegno FFC di Vigevano

€ 15.000

OTHER PROJECTS

Discover the other projects

GMRF#1/2026

Exploring the role of PKD1 in promoting CFTR stability and function at the cell surface

FFC#1/2026

Mapping proteins regulating CFTR mRNA stability to identify new therapeutic targets for nonsense mutations

FFC#2/2026

Evaluating the potential of phosphodiesterase inhibitors to enhance the efficacy of CFTR modulators and support personalized therapeutic approaches